Dan Andersson

Bacteria don't only adapt by mutating genes, they can also adapt by changing how many copies of a gene they carry. Dan Andersson has spent his career showing what that means for antibiotic resistance, and how often it goes undetected.

Professor

Department of Medical Biochemistry and Microbiology at Uppsala University

dan.i.andersson@imbim.uu.se

Research expertise and methodologies

  • Bacterial genetics
  • Experimental evolution
  • Molecular biology

Ongoing research projects

Genome variability and stability

What makes a bacterial genome stable or changeable, and how that sets the tempo of evolution. This work examines the role of gene amplification in adaptive responses, including during antibiotic exposure, and in the birth of entirely new genes, using E. coli and Salmonella as model systems.

Mechanisms and dynamics of resistance evolution

How resistance affects the fitness, virulence and transmission of pathogens, and what determines how fast it develops. Current questions include how bacteria compensate for the cost of resistance, whether reduced antibiotic use can reverse it, how ultra-low antibiotic concentrations in aquatic environments select for resistant mutants, and the prevalence and clinical relevance of heteroresistance.

Antibiotic combinations and drug interactions

Combinations are widely used against resistant infections, but some antibiotics interfere with each other while others enhance each other. This work develops diagnostic methods to detect synergy and antagonism, and investigates the mechanisms underlying them.

Key Publications

  1. Andersson D.I., Slechta E.S., Roth J.R. (1998) Evidence that gene amplification underlies adaptive mutability of the bacterial lac operon. Science 282(5391):1133–1135. https://doi.org/10.1126/science.282.5391.1133
  2. Björkman J., Nagaev I., Berg O.G., Hughes D., Andersson D.I. (2000) Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance. Science 287(5457):1479–1482. https://doi.org/10.1126/science.287.5457.1479
  3. Maisnier-Patin S., Roth J.R., Fredriksson Å., Nyström T., Berg O.G., Andersson D.I. (2005) Genomic buffering mitigates the effects of deleterious mutations in bacteria. Nature Genetics 37:1376–1379. https://doi.org/10.1038/ng1676
  4. Lind P.A., Berg O.G., Andersson D.I. (2010) Mutational robustness of ribosomal protein genes. Science 330(6005):825–827. https://doi.org/10.1126/science.1194617
  5. Näsvall J., Sun L., Roth J.R., Andersson D.I. (2012) Real-time evolution of new genes by innovation, amplification, and divergence. Science 338(6105):384–387. https://doi.org/10.1126/science.1226521
  6. Nicoloff H., Hjort K., Levin B.R., Andersson D.I. (2019) The high prevalence of antibiotic heteroresistance in pathogenic bacteria is mainly caused by gene amplification. Nature Microbiology 4:504–514. https://doi.org/10.1038/s41564-018-0342-0
  7. Pal A., Andersson D.I. (2024) Bacteria can compensate the fitness cost of amplified resistance genes via a bypass mechanism. Nature Communications 15:2333. https://doi.org/10.1038/s41467-024-46571-7
  8. Nicoloff H., Hjort K., Andersson D.I., Wang H. (2024) Three concurrent mechanisms generate gene copy number variation and transient antibiotic heteroresistance. Nature Communications 15:3981. https://doi.org/10.1038/s41467-024-48233-0
  9. Heyman G., Jonsson S., Fatsis-Kavalopoulos N., Hjort K., Nicoloff H., Furebring M., Andersson D.I. (2025) Prevalence, misclassification and clinical consequences of the heteroresistant phenotype in E. coli bloodstream infections: a retrospective cohort study. The Lancet Microbe 6(4):101010. https://doi.org/10.1016/j.lanmic.2024.101010
  10. Fatsis-Kavalopoulos N., Kim Y.K., Chong Y.P., Bae S., Lim S.Y., Kim Y.S., Andersson D.I. (2025) Vancomycin heteroresistance (hVISA) in MRSA links to treatment failure and supports a revised PAP-AUC threshold. Nature Communications 16:11251. https://doi.org/10.1038/s41467-025-66118-8